Stock Comparison
RPRX vs VRTX
Royalty Pharma Plc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$32.38B
$124.70B
P/E (TTM)
29.6
29.2
Forward P/E
46.5
25.8
Price/Sales
13.3
10.2
Price/Book
3.6
6.4
EV/EBITDA
19.1
24.0
Dividend Yield
1.64%
—
Profitability
Net Margin
33.90%
35.50%
Operating Margin
100.30%
38.10%
Return on Equity
13.80%
24.20%
Return on Assets
5.54%
12.10%
Growth (YoY)
Revenue Growth
11.00%
7.80%
Earnings Growth
23.20%
61.40%
Price & Risk
Beta
0.4
0.3
52-Week High
$56.50
$507.92
52-Week Low
$33.57
$362.50
Analyst Target
$59.25
$548.69
Compare RPRX and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.